|
ZNF681 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.025200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.694800E-01 |
| Normal-vs-Stage2 |
2.496600E-01 |
| Normal-vs-Stage3 |
5.162600E-01 |
| Normal-vs-Stage4 |
3.327800E-01 |
| Stage1-vs-Stage2 |
1.135240E-01 |
| Stage1-vs-Stage3 |
1.407550E-01 |
| Stage1-vs-Stage4 |
9.101700E-02 |
| Stage2-vs-Stage3 |
5.452000E-01 |
| Stage2-vs-Stage4 |
9.880200E-01 |
| Stage3-vs-Stage4 |
6.080600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.604200E-01 |
| Normal-vs-AfricanAmerican |
5.267600E-01 |
| Normal-vs-Asian |
5.051000E-01 |
| Caucasian-vs-AfricanAmerican |
5.283800E-01 |
| Caucasian-vs-Asian |
3.938600E-01 |
| AfricanAmerican-vs-Asian |
4.751400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.438800E-01 |
| Normal-vs-Female |
1.187620E-02 |
| Male-vs-Female |
1.284350E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.965400E-01 |
| Normal-vs-Extreme_Weight |
2.350100E-02 |
| Normal-vs-Obese |
5.250600E-01 |
| Normal-vs-Extreme_Obese |
5.186600E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.863200E-03 |
| Normal_Weight-vs-Obese |
6.397600E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.573600E-01 |
| Extreme_Weight-vs-Obese |
5.201500E-03 |
| Extreme_Weight-vs-Extreme_Obese |
6.678000E-01 |
| Obese-vs-Extreme_Obese |
3.425400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.411400E-01 |
| Normal-vs-Age(41-60Yrs) |
8.099600E-01 |
| Normal-vs-Age(61-80Yrs) |
8.369000E-01 |
| Normal-vs-Age(81-100Yrs) |
4.244000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.600210E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.551800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.620100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.688600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.865400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.828600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.203200E-01 |
| Normal-VS-Type2 PRCC |
3.768800E-01 |
| Normal-VS-KIRP CIMP |
8.617900E-02 |
| Normal-VS-Unclassified PRCC |
2.588200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.158400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.142500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.579800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
5.978400E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
8.476100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.692790E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.429800E-01 |
| Normal-vs-N1 |
9.655500E-03 |
| Normal-vs-N2 |
8.604400E-03 |
| N0-vs-N1 |
2.603900E-03 |
| N0-vs-N2 |
1.388410E-01 |
| N1-vs-N2 |
2.659600E-02 |
|
|
